Ronni E. Fuchs is a partner in the Health Sciences Department of Pepper Hamilton LLP, resident in the Princeton office. Ms. Fuchs represents pharmaceutical, biotech, medical device and consumer products manufacturers in products liability, consumer fraud and mass torts litigation.
Ms. Fuchs frequently concentrates on scientific issues arising in litigation, including those relating to clinical trials. She works extensively with in-house research and development personnel both to investigate factual allegations and to prepare witnesses for testimony. She has identified, worked with and deposed expert witnesses in myriad fields, including surgeons, cardiologists, neurologists, oncologists, biostatisticians, hematologists, pharmacologists and toxicologists. She has served as science counsel in multiple securities cases in which the allegations pertained to clinical trial results and/or adverse event reporting.
Ms. Fuchs has assisted clients in responding to Congressional inquiries relating to product safety.
Ms. Fuchs represented Merck in the New Jersey Vioxx litigation, including the successful New Jersey trial defense of Doherty v. Merck. She also served as coordinating counsel for New Jersey Vioxx discovery, involving numerous firms and simultaneous discovery proceedings in 250 cases, as well as lead defense liaison to the court on discovery and case management issues.
Ms. Fuchs served as special counsel for a leading marketer of ephedra-containing dietary supplements, defending claims of personal injury and preparing bellwether stroke cases for trial. She then successfully mediated 175 personal injury cases for the manufacturer-defendant, including the case brought by the estate of Baltimore Orioles pitcher Steve Bechler.
Ms. Fuchs defended consumer fraud class action filings brought in state courts around the country.
In addition to litigation, Ms. Fuchs provides counseling and diligence review for pharmaceutical, medical device and consumer product manufacturers. She counsels companies prior to product approval as well as in response to challenges, such as adverse event reports, results from clinical trials and regulatory actions, and reviews regulatory filings.
Before joining Pepper, Ms. Fuchs was a partner in the Princeton office of Dechert LLP.